Sign Up
Stories
Assertio Faces Lawsuit Amid Stock Decline
Share
Alleged Investor Misconduct Lawsuits Ale...
Alleged Misconduct Spurs Class Actions
Assertio Holdings Faces Investor Lawsuit
AVXL Lawsuit: Deceptive Practices Expose...
Akero Lawsuit: Stock Impact Concerns
Altimmune Faces Investor Investigation
Overview
API
Kessler Topaz Meltzer & Check, LLP files a class action lawsuit against Assertio Holdings, Inc. for securities law violations, citing misleading statements that resulted in investor losses. The approval of a generic version of Assertio's product led to a financial outlook withdrawal and stock price decline.
Ask a question
How does the generic drug approval reflect broader trends in the pharmaceutical industry and its impact on market dynamics?
How might the outcome of the class action lawsuit impact Assertio's future operations and investor trust?
What measures could Assertio take to mitigate the effects of the generic drug competition on its financial performance?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage